Online citations, reference lists, and bibliographies.
← Back to Search

Pancreatic Ductal Adenocarcinoma Can Be Detected By Analysis Of Volatile Organic Compounds (VOCs) In Alveolar Air

A. Princivalle, L. Monasta, G. Butturini, C. Bassi, L. Perbellini
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
BackgroundIn the last decade many studies showed that the exhaled breath of subjects suffering from several pathological conditions has a peculiar volatile organic compound (VOC) profile. The objective of the present work was to analyse the VOCs in alveolar air to build a diagnostic tool able to identify the presence of pancreatic ductal adenocarcinoma in patients with histologically confirmed disease.MethodsThe concentration of 92 compounds was measured in the end-tidal breath of 65 cases and 102 controls. VOCs were measured with an ion-molecule reaction mass spectrometry. To distinguish between subjects with pancreatic adenocarcinomas and controls, an iterated Least Absolute Shrinkage and Selection Operator multivariate Logistic Regression model was elaborated.ResultsThe final predictive model, based on 10 VOCs, significantly and independently associated with the outcome had a sensitivity and specificity of 100 and 84% respectively, and an area under the ROC curve of 0.99. For further validation, the model was run on 50 other subjects: 24 cases and 26 controls; 23 patients with histological diagnosis of pancreatic adenocarcinomas and 25 controls were correctly identified by the model.ConclusionsPancreatic cancer is able to alter the concentration of some molecules in the blood and hence of VOCs in the alveolar air in equilibrium. The detection and statistical rendering of alveolar VOC composition can be useful for the clinical diagnostic approach of pancreatic neoplasms with excellent sensitivity and specificity.
This paper references
Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population
J. Kim (2004)
Breath biomarkers of active pulmonary
M Phillips (2010)
Human breath emissions of VOCs.
J. Fenske (1999)
Possible detection of pancreatic cancer by plasma protein profiling.
K. Honda (2005)
Evaluating markers for the early detection of cancer: overview of study designs and methods
S. Baker (2006)
Volatile metabolites in the exhaled breath of healthy volunteers: their levels and distributions.
D. Smith (2007)
Prediction of heart transplant rejection with a breath test for markers of oxidative stress.
M. Phillips (2004)
Real-time Monitoring of Propofol in Expired Air in Humans Undergoing Total Intravenous Anesthesia
C. Hornuss (2007)
Environmental and occupational exposure to benzene by analysis of breath and blood.
L. Perbellini (1988)
The Iterated Lasso for High-Dimensional Logistic Regression By
J. Huang (2008)
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study
M. Phillips (1999)
Determination of nitrogen dioxide, sulfur dioxide, ozone, and ammonia in ambient air using the passive sampling method associated with ion chromatographic and potentiometric analyses
A. A. Salem (2009)
Chapter 5 - The use of Breath Analysis in Clinical Toxicology
R. D. Stewart (1974)
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Is Cure Possible?
T. Schnelldorfer (2008)
their levels and distributions
D Smith (2018)
Molecular epidemiology of pancreatic cancer
D. Li (2003)
L1 penalized estimation in the Cox proportional hazards model.
J. Goeman (2010)
Molecular breath-gas analysis by online mass spectrometry in mechanically ventilated patients: a new software-based method of CO(2)-controlled alveolar gas monitoring.
M. Dolch (2008)
Variation in volatile organic compounds in the breath of normal humans.
M. Phillips (1999)
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry
M. Ligor (2009)
Detection of lung cancer with volatile markers in the breath.
M. Phillips (2003)
Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia.
M. Moretti (2004)
Breath biomarkers of active pulmonary tuberculosis.
M. Phillips (2010)
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors
G. Peng (2010)
Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction.
P. Paredi (2000)
Inflammation and the development of pancreatic cancer.
B. Farrow (2002)
Progress on molecular markers of pancreatic cancer
T. Grote (2007)
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array
P. Mazzone (2007)
Cancer statistics
N. Dubrawsky (1989)
Cancer Statistics, 2009
A. Jemal (2009)
Indoor, outdoor, and regional summer and winter concentrations of PM10, PM2.5, SO4(2)-, H+, NH4+, NO3-, NH3, and nitrous acid in homes with and without kerosene space heaters.
B. Leaderer (1999)
Smoking and serum CA19‐9 levels according to Lewis and secretor genotypes
S. Kawai (2008)
Volatile organic compounds in exhaled air from patients with lung cancer.
S. Gordon (1985)
Smoking and serum CA19-9 levels according to Lewis and secretor genotypes
川合 紗世 (2009)
Exhaled Air Analysis in Patients with Different Lung Diseases Using Artificial Odour Sensors
I. Taivāns (2009)
Noninvasive detection of lung cancer by analysis of exhaled breath
A. Bajtarevic (2009)
Indoor, outdoor, and regional summer and winter concentrations of PM10, PM2.5, SO4(2)-, H+, NH4+, NO3-, NH3, and nitrous acid in homes with and without kerosene space heaters.
B. Leaderer (1999)
Volatile Markers of Breast Cancer in the Breath
M. Phillips (2003)
Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure
F. Brugnone (1989)
Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study
I. Kushch (2008)
The Adaptive Lasso and Its Oracle Properties
H. Zou (2006)
Monitoring of industrial exposure to organic volatile compounds by analysis of alveolar air and blood
F Brugnone (1987)
A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry
M. Netzer (2009)
The use of breath analysis in clinical toxicology, in Wayland I, Hayes J (ed): Essay in toxicology
RD Stewart (1974)
Regression Shrinkage and Selection via the Lasso
R. Tibshirani (1996)
A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis.
L. Bennett (2009)
Volatile organic compounds in the breath of patients with schizophrenia.
M. Phillips (1995)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.
K. Goonetilleke (2007)
Occupational exposure monitoring using breath analysis.
P. Droz (1986)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar